IE 11 is not supported. For an optimal experience visit our site on another browser.

CDC advisers to address Johnson & Johnson vaccine Friday


As COVID-19 cases continue to climb, health officials are facing a big decision of the fate of the Johnson & Johnson shot after European regulators determined that its benefits outweigh the risk. NBC national correspondent Miguel Almaguer reports for TODAY.